- Home
- MTNB vs PBM Comparison
MTNB vs PBM Comparison
Compare MTNB & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTNB
- PBM
- Stock Information
- Founded
- MTNB 2013
- PBM 1994
- Country
- MTNB United States
- PBM Canada
- Employees
- MTNB N/A
- PBM N/A
- Industry
- MTNB Biotechnology: Pharmaceutical Preparations
- PBM
- Sector
- MTNB Health Care
- PBM
- Exchange
- MTNB Nasdaq
- PBM NYSE
- Market Cap
- MTNB 2.6M
- PBM 2.8M
- IPO Year
- MTNB N/A
- PBM N/A
- Fundamental
- Price
- MTNB $0.73
- PBM $1.92
- Analyst Decision
- MTNB Hold
- PBM
- Analyst Count
- MTNB 1
- PBM 0
- Target Price
- MTNB N/A
- PBM N/A
- AVG Volume (30 Days)
- MTNB 109.7K
- PBM 6.2M
- Earning Date
- MTNB 11-13-2024
- PBM 02-02-2025
- Dividend Yield
- MTNB N/A
- PBM N/A
- EPS Growth
- MTNB N/A
- PBM N/A
- EPS
- MTNB N/A
- PBM N/A
- Revenue
- MTNB N/A
- PBM N/A
- Revenue This Year
- MTNB N/A
- PBM N/A
- Revenue Next Year
- MTNB N/A
- PBM N/A
- P/E Ratio
- MTNB N/A
- PBM N/A
- Revenue Growth
- MTNB N/A
- PBM N/A
- 52 Week Low
- MTNB $0.48
- PBM $1.51
- 52 Week High
- MTNB $21.50
- PBM $945.15
- Technical
- Relative Strength Index (RSI)
- MTNB 54.46
- PBM 36.44
- Support Level
- MTNB $0.48
- PBM $2.07
- Resistance Level
- MTNB $0.60
- PBM $2.54
- Average True Range (ATR)
- MTNB 0.06
- PBM 0.76
- MACD
- MTNB 0.06
- PBM 0.11
- Stochastic Oscillator
- MTNB 83.74
- PBM 6.45
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.